Boston Scientific Inc - Asthmatx Inc
| Phone | 408-419-0100 |
| Fax | 408-419-0101 |
| Forward to a Friend | |
| Email this company |
Contact:
888 Ross Drive
Suite 100
Sunnyvale, CA 94089
Suite 100
Sunnyvale, CA 94089
Asthmatx Inc. is a development stage medical device company located in Sunnyvale, California that is focused on helping patients breathe easier.
Asthmatx Inc. designs, develops and manufactures catheter based medical devices incorporating thermal energy for a variety of indications. Asthmatx has developed the Alair® System, which consists of a single-use device and a controller that delivers radiofrequency energy during an investigative outpatient bronchoscopic procedure known as Bronchial Thermoplasty. The Alair® System provides a different investigational treatment approach for severe asthma that uses radiofrequency energy to apply controlled heat to the airway wall to reduce the amount of airway smooth muscle and restrict its ability to narrow the airway. Bronchial Thermoplasty has been shown to reduce the narrowing of airway passages in response to bronchoconstrictors, and may potentially improve asthma symptoms in patients with this condition. Asthmatx is currently conducting a pivotal study investigation to evaluate the safety and efficacy of the Alair® System for the treatment of severe asthma.
Asthmatx Inc. designs, develops and manufactures catheter based medical devices incorporating thermal energy for a variety of indications. Asthmatx has developed the Alair® System, which consists of a single-use device and a controller that delivers radiofrequency energy during an investigative outpatient bronchoscopic procedure known as Bronchial Thermoplasty. The Alair® System provides a different investigational treatment approach for severe asthma that uses radiofrequency energy to apply controlled heat to the airway wall to reduce the amount of airway smooth muscle and restrict its ability to narrow the airway. Bronchial Thermoplasty has been shown to reduce the narrowing of airway passages in response to bronchoconstrictors, and may potentially improve asthma symptoms in patients with this condition. Asthmatx is currently conducting a pivotal study investigation to evaluate the safety and efficacy of the Alair® System for the treatment of severe asthma.
